{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:39:13Z","timestamp":1759451953404,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003285","name":"Ministerio de Salud de la Naci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.10.003","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T17:30:51Z","timestamp":1571333451000},"page":"330-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of impact of one dose varicella vaccine on the incidence of chickenpox in Argentina"],"prefix":"10.1016","volume":"38","author":[{"given":"Guillermo G.","family":"Barrenechea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo S.","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2019.10.003_b0005","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jama.292.6.704","article-title":"Contagiousness of varicella in vaccinated cases: A household contact study","volume":"292","author":"Seward","year":"2004","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.vaccine.2019.10.003_b0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CMR.9.3.361","article-title":"Varicella-zoster virus","volume":"9","author":"Arvin","year":"1996","journal-title":"Clin Microbiol Rev [Internet]"},{"issue":"33","key":"10.1016\/j.vaccine.2019.10.003_b0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.7748\/ns2014.04.28.33.52.e8249","article-title":"Varicella zoster virus: chickenpox and shingles","volume":"28","author":"Gould","year":"2014","journal-title":"Nurs Stand [Internet]"},{"issue":"7","key":"10.1016\/j.vaccine.2019.10.003_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v10070349","article-title":"Molecular aspects of varicella-zoster virus latency","volume":"10","author":"Depledge","year":"2018","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.003_b0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10198-003-0200-7","article-title":"The burden of varicella in Germany: Potential risks and economic impact","volume":"5","author":"Banz","year":"2004","journal-title":"Eur J Heal Econ"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.003_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-015-1514-y","article-title":"The humanistic, economic and societal burden of Herpes Zoster in Europe: A critical review","volume":"15","author":"Gater","year":"2015","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2019.10.003_b0035","first-page":"175","article-title":"Varicella epidemiology in Latin America and the Caribbean","volume":"17","author":"\u00c1vila-Ag\u00fcero","year":"2018","journal-title":"Expert Rev Vaccines [Internet]"},{"issue":"12","key":"10.1016\/j.vaccine.2019.10.003_b0040","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/INF.0b013e31826ff3a5","article-title":"Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean\u2013a systematic review and meta-analysis","volume":"31","author":"Bardach","year":"2012","journal-title":"Pediatr Infect Dis J [Internet]"},{"key":"10.1016\/j.vaccine.2019.10.003_b0045","unstructured":"Ministerio de Salud Presidencia de la Naci\u00f3n. Fundamentos de la introucci\u00f3n de la vacuna contra rotavirus al calendario de inmunizaciones 2015. 2015;1\u201366. Available from: http:\/\/www.msal.gob.ar\/images\/stories\/bes\/graficos\/0000000586cnt-2014-12_lineamientos-rotavirus.pdf."},{"issue":"2","key":"10.1016\/j.vaccine.2019.10.003_b0050","first-page":"32","article-title":"Relationship between climatic factors and cases of Varicella in Tucum\u00e1n, Argentina","volume":"1","author":"Barrenechea","year":"2017","journal-title":"Investigaci\u00f3n en Salud [Internet]"},{"key":"10.1016\/j.vaccine.2019.10.003_b0055","unstructured":"Cenoz MG, Castilla J, Montes Y, Mor\u00e1n J, Salaberri A, El\u00eda F, et al. Incidencia de la varicela y el herpes z\u00f3ster antes de la introducci\u00f3n de la vacunaci\u00f3n sistem\u00e1tica infantil en Navarra, 2005-2006 Varicella and herpes zoster incidence prior to the introduction of systematic child vaccination in Navarre, 2005-2006. 2008;30:2005\u20136."},{"issue":"3","key":"10.1016\/j.vaccine.2019.10.003_b0060","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0891-5520(05)70309-3","article-title":"Vaccine development","volume":"10","author":"Takahashi","year":"1996","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.vaccine.2019.10.003_b0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.eimc.2015.05.005","article-title":"Vacunas frente al virus de la varicela z\u00f3ster","volume":"33","author":"Salleras","year":"2015","journal-title":"Enferm Infecc Microbiol Clin [Internet]"},{"key":"10.1016\/j.vaccine.2019.10.003_b0070","doi-asserted-by":"crossref","unstructured":"Dennehy PH, Dennehy PH, Doctor D, Protocol J, Queries R, Network Z. Active immunization in the United States: Developments over the past decade. 2007;14(4):872\u2013908.","DOI":"10.1128\/CMR.14.4.872-908.2001"},{"issue":"89","key":"10.1016\/j.vaccine.2019.10.003_b0075","first-page":"265","article-title":"Varicella and herpes zoster vaccines: WHO position paper, June 2014","volume":"25","author":"Organization","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2019.10.003_b0080","unstructured":"Ministerio de Salud. Resoluci\u00f3n 1029\/2014. Programa Nacional de Control de Enfermedades Inmunoprevenibles. Incorporaci\u00f3n; 2014."},{"key":"10.1016\/j.vaccine.2019.10.003_b0085","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2018 global summary. World Health Organization; 2018."},{"key":"10.1016\/j.vaccine.2019.10.003_b0090","unstructured":"Direcci\u00f3n de Control de Enfermedades Inmunoprevenibles. Coberturas de Vacunaci\u00f3n por Jurisdicci\u00f3n Calendario Nacional de Vacunaci\u00f3n 2009-2017 [Internet]. 2017. Available from: http:\/\/www.msal.gob.ar\/images\/stories\/bes\/graficos\/0000001120cnt-2018_coberturas-vacunacion-por-jurisdiccion-2009-2017.pdf."},{"key":"10.1016\/j.vaccine.2019.10.003_b0095","doi-asserted-by":"crossref","unstructured":"Sciences RB, Sato RC. Disease management with ARIMA model in time series Gerenciamento de doen\u00e7as utilizando s\u00e9ries temporais com o modelo ARIMA. 2013;11(12):128\u201331.","DOI":"10.1590\/S1679-45082013000100024"},{"key":"10.1016\/j.vaccine.2019.10.003_b0100","unstructured":"Ministerio de Defensa. Instituto Geogr\u00e1fico Nacional [Internet]. Available from: http:\/\/www.ign.gob.ar\/."},{"key":"10.1016\/j.vaccine.2019.10.003_b0105","unstructured":"Ministerio de Hacienda de la Naci\u00f3n Argentina. Instituto Nacional de Estad\u00edsticas y Censos [Internet]. Available from: https:\/\/www.indec.gob.ar\/."},{"key":"10.1016\/j.vaccine.2019.10.003_b0110","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2017."},{"issue":"2001","key":"10.1016\/j.vaccine.2019.10.003_b0115","first-page":"1","article-title":"Approximate Bayesian inference for latent Gaussian models using approximate Bayesian inference for latent Gaussian models using integrated nested Laplace approximations","volume":"Series B","author":"H\u00e5vard","year":"2007","journal-title":"J R Stat Soc [Internet]"},{"key":"10.1016\/j.vaccine.2019.10.003_b0120","doi-asserted-by":"crossref","unstructured":"Rue H, Riebler A, S\u00f8rbye SH, Illian JB, Simpson DP, Lindgren FK. Bayesian computing with INLA: A review. 2016;(December):1\u201327. Available from: http:\/\/arxiv.org\/abs\/1604.00860.","DOI":"10.1146\/annurev-statistics-060116-054045"},{"key":"10.1016\/j.vaccine.2019.10.003_b0125","unstructured":"Argentina C de la N. Proteccion De Los Datos Personales [Internet]. 2000. p. 1\u201315. Available from: http:\/\/servicios.infoleg.gob.ar\/infolegInternet\/anexos\/60000-64999\/64790\/norma.htm."},{"issue":"16","key":"10.1016\/j.vaccine.2019.10.003_b0130","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.vaccine.2016.02.058","article-title":"Universal varicella vaccine immunization in Japan","volume":"34","author":"Yoshikawa","year":"2016","journal-title":"Vaccine [Internet]"},{"issue":"37","key":"10.1016\/j.vaccine.2019.10.003_b0135","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1016\/j.vaccine.2017.07.090","article-title":"Evaluating the effectiveness of the universal immunization program against varicella in Japanese children","volume":"35","author":"Hattori","year":"2017","journal-title":"Vaccine [Internet]"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.003_b0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.aprim.2017.01.010","article-title":"Descenso de la incidencia de la varicela en la Comunidad de Madrid tras la vacunaci\u00f3n infantil universal. A\u00f1os 2001-2015","volume":"50","author":"Garc\u00eda Comas","year":"2018","journal-title":"Aten Primaria"},{"issue":"10","key":"10.1016\/j.vaccine.2019.10.003_b0145","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/adc.2007.126243","article-title":"Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997\u20132005","volume":"93","author":"Quian","year":"2008","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.vaccine.2019.10.003_b0150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/14760584.2017.1247700","article-title":"Varicella prevention in Costa Rica: impact of a one-dose schedule universal vaccination","volume":"16","author":"Avila-Aguero","year":"2017","journal-title":"Expert Rev Vaccines [Internet]"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.003_b0155","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4161\/hv.36153","article-title":"Effectiveness of vaccination against varicella in children under 5 years in puglia, italy 2006\u20132012","volume":"11","author":"Tafuri","year":"2015","journal-title":"Hum Vaccines Immunother"},{"issue":"47","key":"10.1016\/j.vaccine.2019.10.003_b0160","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1016\/j.vaccine.2011.09.024","article-title":"Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program","volume":"29","author":"Tanuseputro","year":"2011","journal-title":"Vaccine [Internet]"},{"issue":"27","key":"10.1016\/j.vaccine.2019.10.003_b0165","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1016\/j.vaccine.2017.05.013","article-title":"Impact and effectiveness of childhood varicella vaccine program in Queensland, Australia","volume":"35","author":"Sheridan","year":"2017","journal-title":"Vaccine [Internet]"},{"issue":"37","key":"10.1016\/j.vaccine.2019.10.003_b0170","first-page":"e14","article-title":"Outbreak of varicella in a highly vaccinated preschool population","volume":"2015","author":"Fu","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2019.10.003_b0175","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/14760584.2017.1343669","article-title":"Varicella vaccination - the global experience","volume":"16","author":"Wutzler","year":"2017","journal-title":"Expert Rev Vaccines [Internet]"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.003_b0180","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajic.2017.07.029","article-title":"Incidence rate of breakthrough varicella observed in healthy children after 1 or 2 doses of varicella vaccine: Results from a meta-analysis","volume":"46","author":"Zhu","year":"2018","journal-title":"Am J Infect Control [Internet]"},{"issue":"19","key":"10.1016\/j.vaccine.2019.10.003_b0185","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1016\/j.vaccine.2010.02.079","article-title":"Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster","volume":"28","author":"Brisson","year":"2010","journal-title":"Vaccine [Internet]"},{"issue":"7","key":"10.1016\/j.vaccine.2019.10.003_b0190","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.vaccine.2010.12.032","article-title":"The changing epidemiology of varicella incidence after implementation of the one-dose varicella vaccination policy","volume":"29","author":"Bin","year":"2011","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.vaccine.2019.10.003_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.epidem.2016.11.001","article-title":"Estimation of age-specific rates of reactivation and immune boosting of the varicella zoster virus","volume":"19","author":"Marinelli","year":"2017","journal-title":"Epidemics [Internet]"},{"key":"10.1016\/j.vaccine.2019.10.003_b0200","doi-asserted-by":"crossref","unstructured":"Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster\u202f: implications for mass vaccination against chickenpox. 2002;20:2500\u20137.","DOI":"10.1016\/S0264-410X(02)00180-9"},{"issue":"5","key":"10.1016\/j.vaccine.2019.10.003_b0205","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States, 1995\u20132000","volume":"287","author":"Seward","year":"2002","journal-title":"J Am Med Assoc"},{"issue":"6","key":"10.1016\/j.vaccine.2019.10.003_b0210","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1017\/S0950268811001786","article-title":"The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000\u20132008","volume":"140","author":"Chao","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.10.003_b0215","series-title":"Human vaccines and immunotherapeutics","first-page":"645","article-title":"Global impact of varicella vaccination programs [Internet]","author":"Varela","year":"2019"},{"issue":"17","key":"10.1016\/j.vaccine.2019.10.003_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/1560-7917.ES.2017.22.17.30521","article-title":"Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015","volume":"22","author":"Rieck","year":"2017","journal-title":"Eurosurveillance"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.003_b0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4161\/hv.34311","article-title":"Impact of universal vaccination against varicella in Italy: Experiences from eight Italian Regions","volume":"11","author":"Bechini","year":"2015","journal-title":"Hum Vaccines Immunother"},{"issue":"9","key":"10.1016\/j.vaccine.2019.10.003_b0230","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1080\/21645515.2018.1475813","article-title":"Effectiveness and impact of a single-dose vaccine against chickenpox in the community of Madrid between 2001 and 2015","volume":"14","author":"Latasa","year":"2018","journal-title":"Hum Vaccines Immunother"},{"issue":"32","key":"10.1016\/j.vaccine.2019.10.003_b0235","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1016\/j.vaccine.2015.06.029","article-title":"Children with breakthrough varicella infection requiring hospitalization in Turkey (VARICOMP Study 2008\u20132013)","volume":"33","author":"Dinleyici","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.003_b0240","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.vaccine.2017.12.011","article-title":"Single-dose varicella vaccine effectiveness in Brazil: A case-control study","volume":"36","author":"Andrade","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2019.10.003_b0245","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.vaccine.2017.11.057","article-title":"Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil","volume":"36","author":"Scotta","year":"2018","journal-title":"Vaccine [Internet]"},{"issue":"49","key":"10.1016\/j.vaccine.2019.10.003_b0250","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1016\/j.vaccine.2008.07.021","article-title":"Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil","volume":"26","author":"Valentim","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2019.10.003_b0255","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/14760584.2018.1433999","article-title":"Effectiveness, immunogenicity and safety of one vs. two-dose varicella vaccination: a meta-analysis","volume":"17","author":"Yin","year":"2018","journal-title":"Expert Rev Vaccines [Internet]"},{"issue":"4","key":"10.1016\/j.vaccine.2019.10.003_b0260","doi-asserted-by":"crossref","first-page":"e20152802","DOI":"10.1542\/peds.2015-2802","article-title":"Varicella vaccine effectiveness in preventing community transmission in the 2-dose era","volume":"137","author":"Perella","year":"2016","journal-title":"Pediatrics [Internet]"},{"key":"10.1016\/j.vaccine.2019.10.003_b0265","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1542\/peds.2013-4251","article-title":"Impact of vaccination on the epidemiology of varicella: 1995\u20132009","volume":"134","author":"Baxter","year":"2014","journal-title":"Pediatrics [Internet]"},{"issue":"4","key":"10.1016\/j.vaccine.2019.10.003_b0270","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/13696998.2018.1431919","article-title":"Economic burden of varicella in children 1\u201312 years of age in Argentina, 2009\u20132014","volume":"21","author":"Giglio","year":"2018","journal-title":"J Med Econ [Internet]"},{"issue":"52","key":"10.1016\/j.vaccine.2019.10.003_b0275","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1016\/j.vaccine.2014.10.076","article-title":"Varicella vaccination coverage inverse correlation with varicella hospitalizations in Spain","volume":"32","author":"Gil-Prieto","year":"2014","journal-title":"Vaccine [Internet]"},{"issue":"5","key":"10.1016\/j.vaccine.2019.10.003_b0280","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.tmaid.2013.06.002","article-title":"Epidemiology and impact of varicella vaccination: A longitudinal study 1994-2011","volume":"11","author":"Al-Tawfiq","year":"2013","journal-title":"Travel Med Infect Dis [Internet]"},{"issue":"42","key":"10.1016\/j.vaccine.2019.10.003_b0285","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1016\/j.vaccine.2013.08.022","article-title":"The impact of the universal infant varicella immunization strategy on Canadian varicella-related hospitalization rates","volume":"31","author":"Waye","year":"2013","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.vaccine.2019.10.003_b0290","unstructured":"Diputados C de. Ley de Vacunas 2018. 1983; Available from: https:\/\/www4.hcdn.gob.ar\/dependencias\/dcomisiones\/periodo-136\/136-810.pdf."},{"key":"10.1016\/j.vaccine.2019.10.003_b0295","unstructured":"Naci\u00f3n C de D de la. Nueva Ley de Vacunas. 2018;1\u20139. Available from: https:\/\/www4.hcdn.gob.ar\/dependencias\/dcomisiones\/periodo-136\/136-810.pdf."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:39:15Z","timestamp":1759401555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19313623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19313623"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of impact of one dose varicella vaccine on the incidence of chickenpox in Argentina","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}